Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection.
暂无分享,去创建一个
Lutz Heinemann | Steven Keith | Diane E. Sutter | L. Heinemann | C. Kapitza | L. Nosek | B. Ginsberg | Ronald J Pettis | Barry Ginsberg | Laurence Hirsch | Diane Sutter | Elaine McVey | Noel G Harvey | Marcus Hompesch | Leszek Nosek | Christoph Kapitza | N. Harvey | L. Hirsch | R. Pettis | M. Hompesch | Steven Keith | Elaine McVey
[1] M. Prausnitz,et al. Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. , 2009, Diabetes technology & therapeutics.
[2] Israel Hartman. Insulin Analogs: Impact on Treatment Success, Satisfaction, Quality of Life, and Adherence , 2008, Clinical Medicine & Research.
[3] Milton V. Marshall,et al. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. , 2008, Radiology.
[4] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[5] A. Laurent,et al. Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. , 2007, Vaccine.
[6] E. Gale,et al. Inhaled insulin: gone with the wind? , 2007, Diabetologia.
[7] Claudio Cobelli,et al. GIM, Simulation Software of Meal Glucose—Insulin Model , 2007, Journal of diabetes science and technology.
[8] L. Heinemann,et al. Inhaled Insulin: Take a Deep Breath, but How? , 2008, Journal of diabetes science and technology.
[9] Lutz Heinemann. Continuous Glucose Monitoring and Clinical Trials , 2009, Journal of diabetes science and technology.
[10] J. Leahy. Basal-Prandial Insulin Therapy: Scientific Concept Review and Application , 2006, The American journal of the medical sciences.
[11] S. Besuschio,et al. Evaluation of innovative skin-marking technique performed before thyroid ultrasound-guided fine-needle aspiration biopsies. , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[12] R. DeFronzo,et al. Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.
[13] R. Holman,et al. 10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.
[14] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[15] Jaromír Antoch,et al. Permutation tests in change point analysis , 2001 .
[16] L. Heinemann,et al. Oral Insulin and Buccal Insulin: A Critical Reappraisal , 2009, Journal of diabetes science and technology.
[17] L. Heinemann,et al. Alternative routes of administration as an approach to improve insulin therapy: update on dermal, oral, nasal and pulmonary insulin delivery. , 2001, Current pharmaceutical design.
[18] L Heinemann,et al. Prandial Glycaemia After a Carbohydrate‐rich Meal in Type I Diabetic Patients: Using the Rapid Acting Insulin Analogue [Lys(B28), Pro(B29)] Human Insulin , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[19] S. Haines,et al. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization , 2010, Current medical research and opinion.
[20] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[21] T. Lauritzen,et al. Limitations to subcutaneous insulin administration in type 1 diabetes , 2003, Diabetes, obesity & metabolism.
[22] James Albers,et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. , 2006, Diabetes care.
[23] P. Laurent,et al. Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system. , 2007, Vaccine.
[24] D. Bates,et al. Mixed-Effects Models in S and S-PLUS , 2001 .
[25] Shi Ke,et al. Quantitative imaging of lymph function. , 2007, American journal of physiology. Heart and circulatory physiology.
[26] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[27] S. Brunton. Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. , 2008, The American journal of medicine.
[28] D. Bruttomesso,et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. , 1999, Diabetes.
[29] A. Mooradian,et al. A Critical Appraisal of the Role of Insulin Analogues in the Management of Diabetes Mellitus , 2012, Drugs.
[30] B. Zinman,et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy , 2008, Diabetologia.
[31] B. Ploeger,et al. Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research. , 2008, Trends in pharmacological sciences.
[32] Matthew D. Davis,et al. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. , 2000, The New England journal of medicine.
[33] B. Zinman,et al. Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy , 2009, Diabetes Care.
[34] A. Berghold,et al. Systematic Review and Meta-analysis of Short-Acting Insulin Analogues in Patients With Diabetes Mellitus , 2006 .
[35] V. Basevi. Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.
[36] D. Tobin,et al. Biochemistry of human skin--our brain on the outside. , 2006, Chemical Society reviews.
[37] Scott A. Kaestner,et al. Microneedle-Based Intradermal Delivery Enables Rapid Lymphatic Uptake and Distribution of Protein Drugs , 2010, Pharmaceutical Research.